AMO Cleared To Market Myopia IOL; Staar Surgical Awaits Site Re-Inspection
This article was originally published in The Gray Sheet
Executive Summary
Ophtec/Advanced Medical Optics will start U.S. clinical trials next spring for a foldable version of their phakic intraocular lens to correct near-sightedness, building on two years of European study data
You may also be interested in...
AMO To Surround Eye Surgeons With Refractive Offerings After Visx Purchase
Advanced Medical Optics' acquisition of pure-play LASIK manufacturer Visx will enable the combined entity to more effectively market laser eye surgery to physicians performing both refractive and cataract procedures
AMO To Surround Eye Surgeons With Refractive Offerings After Visx Purchase
Advanced Medical Optics' acquisition of pure-play LASIK manufacturer Visx will enable the combined entity to more effectively market laser eye surgery to physicians performing both refractive and cataract procedures
Staar Surgical Visian ICL
Implantable contact lens PMA approval for myopia likely will be delayed beyond the Oct. 22 American Academy of Ophthalmologists meeting, the firm says, following Sept. 23 receipt of 36 "FDA 483" observations stemming from a re-inspection of its Monrovia, Calif. manufacturing facility. An initial inspection led to a December 2003 warning letter and subsequent Staar corrections. Current observations include quality system and complaint handling issues. Staar is preparing a written response and will undertake further corrective action (1"The Gray Sheet" Sept. 20, 2004, p. 3)...